Improvements in Immune Function and Activation with 48-Week Darunavir/Ritonavir-Based Therapy: GRACE Substudy

Christos Tsoukas, Louise Gilbert, Trevor Lewis, George Hatzakis, Ron Falcon, Joseph Mrus

Open source

DOI
10.1155/2013/358294
Published
2013-12-12
Container
ISRN AIDS
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2013/358294,
  title = {Improvements in Immune Function and Activation with 48-Week Darunavir/Ritonavir-Based Therapy: GRACE Substudy},
  author = {Christos Tsoukas and Louise Gilbert and Trevor Lewis and George Hatzakis and Ron Falcon and Joseph Mrus},
  year = {2013},
  journal = {ISRN AIDS},
  doi = {10.1155/2013/358294},
  url = {https://doi.org/10.1155/2013/358294}
}

RIS

TY  - JOUR
TI  - Improvements in Immune Function and Activation with 48-Week Darunavir/Ritonavir-Based Therapy: GRACE Substudy
AU  - Christos Tsoukas
AU  - Louise Gilbert
AU  - Trevor Lewis
AU  - George Hatzakis
AU  - Ron Falcon
AU  - Joseph Mrus
PY  - 2013
JO  - ISRN AIDS
DO  - 10.1155/2013/358294
UR  - https://doi.org/10.1155/2013/358294
ER  - 

APA

Tsoukas, C., Gilbert, L., Lewis, T., Hatzakis, G., Falcon, R., & Mrus, J. (2013). Improvements in Immune Function and Activation with 48-Week Darunavir/Ritonavir-Based Therapy: GRACE Substudy. ISRN AIDS. https://doi.org/10.1155/2013/358294

Source records